Critical role of mast cells in inflammatory diseases and the effect of acute stress

Journal of Neuroimmunology

Volumn 146, Issue 1-2, 2004, Pages 1-12

  Theoharides, Theoharis C ^a,c   Cochrane, David E ^b  

^a TUFTS MEDICAL CENTER   (United States)

^b TUFTS UNIVERSITY   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Mast cells; Stress; Vascular permeability

Indexed keywords

ANAPHYLATOXIN; ANTALARMIN; CHONDROITIN SULFATE; CROMOGLYCATE DISODIUM; CYPROHEPTADINE; CYTOKINE; FC RECEPTOR; HYDROXYZINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN E; NEUROPEPTIDE; PROXICROMIL; QUERCETIN;

ACUTE DISEASE; ALLERGIC REACTION; ANIMAL; ARTHRITIS; ASTHMA; ATHEROSCLEROSIS; ATOPIC DERMATITIS; CARDIOVASCULAR DISEASE; CELL ACTIVATION; CHRONIC PROSTATITIS; CLINICAL TRIAL; CORONARY ARTERY ATHEROSCLEROSIS; DIGESTIVE SYSTEM INFLAMMATION; ENCEPHALITIS; FIBROMYALGIA; HEART MUSCLE ISCHEMIA; HUMAN; IMMUNOLOGY; INFLAMMATION; INFLAMMATORY DISEASE; INTERSTITIAL CYSTITIS; IRRITABLE COLON; MAST CELL; MAST CELL DEGRANULATION; MEDIATOR RELEASE; MENINGITIS; METABOLISM; MIGRAINE; MULTIPLE SCLEROSIS; NEUROFIBROMATOSIS; NONHUMAN; OSTEOARTHRITIS; PATHOLOGY; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; SCLERODERMA; SILENT MYOCARDIAL INFARCTION; SKIN INFLAMMATION; STRESS; UNSTABLE ANGINA PECTORIS;

EID: 0347993174     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2003.10.041     Document Type: Review

References (241)

1. Ackerman K.D., Heyman R., Rabin B.S., Anderson B.P., Houck P.R., Frank E., Baum A. Stressful life events precede exacerbations of multiple sclerosis. Psychosom. Med. 64:2002;916-920.
2. Alagiri M., Chottiner S., Ratner V., Slade D., Hanno P.M. Interstitial cystitis: unexplained associations with other chronic disease and pain syndromes. Urology. 49(Suppl. 5A):1997;52-57.
3. Alexacos N., Pang X., Boucher W., Cochrane D.E., Sant G.R., Theoharides T.C. Neurotensin mediates rat bladder mast cell degranulation triggered by acute psychological stress. Urology. 53:1999;1035-1040.
4. Bello A.R., Hernandez G., Gonzalez M., Reyes R., Negrin I., Marrero A., Sanchez-Criado J.E., Tramu G., Alonso R. Immunoreactive neurotensin in gonadotrophs and thyrotrophs is regulated by sex steroid hormones in the female rat. J. Neuroendocrinol. 11:1999;785-794.
5. Belova I., Jonsson G. Blood-brain barrier permeability and immobilization stress. Acta Physiol. Scand. 116:1982;21-29.
6. Benoist C., Mathis D. Mast cells in autoimmune disease. Nature. 420:2002;875-878.
7. Benyon R., Robinson C., Church M.K. Differential release of histamine and eicosanoids from human skin mast cells activated by IgE-dependent and non-immunological stimuli. Br. J. Pharmacol. 97:1989;898-904.
8. Bienenstock J. Stress and asthma: the plot thickens. Am. J. Respir. Crit. Care Med. 165:2002;1034-1035.
9. Bradding P. The role of the mast cell in asthma: a reassessment. Curr. Opin. Allergy Clin. Immunol. 3:2003;45-50.
10. Brenner T., Soffer D., Shalit M., Levi-Schaffer F. Mast cells in experimental allergic encephalomyelitis: characterization, distribution in the CNS and in vitro activation by myelin basic protein and neuropeptides. J. Neurol. Sci. 122:1994;210-213.
11. Brightling C.E., Bradding P., Pavord I.D., Wardlaw A.J. New insights into the role of the mast cell in asthma. Clin. Exp. Allergy. 33:2003;550556.
12. Brown M., Tanzola M., Robbie-Ryan M. Mechanisms underlying mast cell influence on EAE disease course. Mol. Immunol. 38:2002;1373-1378.
13. Bugajski A.J., Chlap Z., Bugajski J., Borycz J. Effect of compound 48/80 on mast cells and biogenic amine levels in brain structures and on corticosterone secretion. J. Physiol. Pharmacol. 46:1995;513-522.
14. Bugajski A.J., Chlap Z., Gadek-Michalska A., Borycz J., Bugajski J. Degranulation and decrease in histamine levels of thalamic mast cells coincides with corticosterone secretion induced by compound 48/80. Inflamm. Res. 44(Suppl. 1):1995;S50-S51.
15. Buske-Kirschbaum A., Hellhammer D.H. Endocrine and immune responses to stress in chronic inflammatory skin disorders. Ann. N.Y. Acad. Sci. 992:2003;231-240.
16. Carraway R., Cochrane D.E., Lansman J.B., Leeman S.E., Paterson B.M., Welch H.J. Neurotensin stimulates exocytotic histamine secretion from rat mast cells and elevates plasma histamine levels. J. Physiol. 323:1982;403-414.
17. Carraway R.E., Mitra S.P., Cochrane D.E. Structure of a biologically active neurotensin-related peptide obtained from pepsin-treated albumin(s). J. Biol. Chem. 262:1987;5968-5973.
18. Carraway R.E., Cochrane D.E., Boucher W., Mitra S.P. Structures of histamine-releasing peptides formed by the action of acid proteases on mammalian albumin(s). J. Immunol. 143:1989;1680-1684.
19. Castagliuolo I., LaMont J.T., Letourneau R., Kelly C., O'Keane J.C., Jaffer A., Theoharides T.C., Pothoulakis C. Neuronal involvement in the intestinal effects of Clostridium difficile toxin A and vibrio cholera entertoxin in rat ileum. Gastroenterology. 107:1994;657-665.
20. Castagliuolo I., LaMont J.T., Qiu B., Fleming S.M., Bhaskar K.R., Nikulasson S.T., Kornetsky C., Pothoulakis C. Acute stress causes mucin release from rat colon: role of corticotropin releasing factor and mast cells. Am. J. Physiol. 271:1996;884-892.
21. Castagliuolo I., Wershil B.K., Karalis K., Pasha A., Nikulasson S.T., Pothoulakis C. Colonic mucin release in response to immobilization stress is mast cell dependent. Am. J. Physiol. 274:1998;1000-1094.
22. Castagliuolo I., Wang C.C., Valenich L., Pasha A., Nikulassin S., Carraway R.E. Neurotensin is a proinflammatory neuropeptide in colonic inflammation. J. Clin. Invest. 103:1999;843-849.
23. Chandler N., Jacobson S., Connolly R., Esposito P., Theoharides T.C. Acute stress shortens the time of onset of experimental allergic encephalomyelitis (EAE) in SJL/J mice. Brain Behav. Immun. 16:2002;757-763.
24. Charlesworth E.N. The role of basophils and mast cells in acute and late reactions in the skin. Allergy. 52(34 Suppl.):1997;31-43.
25. Chiu A., Chon S.Y., Kimball A.B. The response of skin disease to stress: changes in the severity of acne vulgaris as affected by examination stress. Arch. Dermatol. 139:2003;897-900.
26. Cho S.H., Anderson A.J., Oh C.K. Importance of mast cells in the pathophysiology of asthma. Clin. Rev. Allergy Immunol. 22:2002;161-174.
27. Christian E.P., Undem B.J., Weinreich D. Endogenous histamine excites neurones in the guinea-pig superior cervical ganglion in vitro. J. Physiol. 409:1989;297-312.
28. Christmas T.J., Rode J., Chapple C.R., Milroy E.J., Turner-Warwick R.T. Nerve fibre proliferation in interstitial cystitis. Virchows Arch. A. 416:1990;447-451.
29. Chrousos G.P. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N. Engl. J. Med. 332:1995;1351-1362.
30. Church M.K., Clough G.F. Human skin mast cells: in vitro and in vivo studies. Ann. Allergy, Asthma, and Immun. 83:1999;471-475.
31. Church M.K., Lowman M.A., Rees P.H., Benyon R.C. Mast cells, neuropeptides and inflammation. Agents Actions. 27:1989;8-16.
32. Clejan S., Japa S., Clemetson C., Hasabnis S.S., David O., Talamo J.V. Blood histamine is associated with coronary artery disease, cardiac events and severity of inflammation and atherosclerosis. J. Cell. Mol. Med. 6:2002;502-583.
33. Clifton V.L., Crompton R., Smith R., Wright I.M. Microvascular effects of CRH in human skin vary in relation to gender. J. Clin. Endocrinol. Metab. 87:2002;267-270.
34. Cochrane D.E., Boucher W., Carraway R.E. Generation of histamine-releasing activity from serum albumin by medium derived from stimulated neutrophils of rat. Br. J. Pharmacol. 97:1989;524-532.
35. Cochrane D.E., Carraway R.E., Feldberg R.S., Boucher W., Gelfand J.M. Stimulated rat mast cells generate histamine-releasing peptide from albumin. Peptides. 14:1993;117-123.
36. Cochrane D.E., Carrawan R.E., Miller L.A., Feldberg R.S., Bernheim H. Histamine releasing peptide (HRP) has proinflammatory effects and is present at sites of inflammation. Biochem. Pharmacol. 66:2003;331-342.
37. Constantinides P. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation. 92:1995;1083-1088.
38. Conti P., Pang X., Boucher W., Letourneau R., Reale M., Barbacane R.C., Thibault J., Theoharides T.C. Impact of RANTES and MCP-1 chemokines on in vivo basophilic mast cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood. 89:1997;4120-4127.
39. v mice. FASEB J. 12:1998;1693-1700.
40. Conti P., Reale M., Barbacane R.C., Castellani M.L., Orso C. Differential production of RANTES and MCP-1 in synovial fluid from the inflamed human knee. Immunol. Lett. 80:2002;105-111.
41. Crisp A.J., Champan C.M., Kirkham S.E., Schiller A.L., Keane S.M. Articular mastocytosis in rheumatoid arthritis. Arthritis Rheum. 27:1984;845-851.
42. Cromlish J.A., Seidah N.G., Marcinkiewicz M., Hamelin J., Johnson D.A., Chretien M. Human pituitary tryptase: molecular forms, NH2-terminal sequence, immunocytochemical localization, and specificity with prohormone and fluorogenic substrates. J. Biol. Chem. 262:1987;1363-1373.
43. Curhan G.C., Speizer F.E., Hunter D.J., Curhan S.G., Stampfer M.J. Epidemiology of interstitial cystitis: a population based study. J. Urol. 161:1999;549-552.
44. de Paulis A., Marino I., Ciccarelli A., de Crescenzo G., Concardi M., Verga L., Arbustini E., Marone G. Human synovial mast cells: I. Ultrastructural in situ and in vitro immunologic characterization. Arthritis Rheum. 39:1996;1222-1233.
45. de Paulis A., Ciccarelli A., Marinò I., de Crescenzo G., Marinò D., Marone G. Human synovial mast cells: II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs. Arthritis Rheum. 40:1997;469-478.
46. De Vreis H.E., Kuiper J., de Boer A.G., Van Berkel T.J.C., Breimer D.D. The blood-brain barrier in neuroinflammatory diseases. Pharmacol. Rev. 49:1997;143-155.
47. Deanfield J.E., Shea M., Kensett M., Horlock P., Wilson R.A., de Landsheare C.M., Selwyn A.P. Silent myocardial ischaemic due to mental stress. Lancet. 2(8410):1984;1001-1005.
48. Deedwaria P.C. Mental stress, pain perception and risk of silent ischemia. J. Am. J. Cardiol. 25(7):1995;1504-1506.
49. Deliargyris E.N., Raymond R.J., Theoharides T.C., Boucher W.S., Tate D.A., Dehmer G.J. Sites of interleukin-6 release in patients with acute coronary syndromes and in patients with congestive heart failure. Am. J. Cardiol. 86:2000;913-918.
50. Dhabhar F., McEwen B.S. Stress-induced enhancement of antigen-specific cell-mediated immunity. J. Immunol. 156:1996;2608-2615.
51. Dhabhar F.S., McEwen B.S. Enhancing versus suppressive effects of stress hormones on skin immune function. Proc. Natl. Acad. Sci. U. S. A. 96:1999;1059-1064.
52. Dietsch G.N., Hinrichs D.J. Mast cell proteases liberate encephalitogenic fragments from intact myelin. Cell. Immunol. 135:1991;541-548.
53. Dimitriadou V., Aubineau P., Taxi J., Seylaz J. Ultrastructural evidence for a functional unit between nerve fibers and type II cerebral mast cells in the cerebral vascular wall. Neuroscience. 22:1987;621-630.
54. Dimitriadou V., Lambracht-Hall M., Reichler J., Theoharides T.C. Histochemical and ultrastructural characteristics of rat brain perivascular mast cells stimulated with compound 48/80 and carbachol. Neuroscience. 39:1990;209-224.
55. Dimitriadou V., Buzzi M.G., Moskowitz M.A., Theoharides T.C. Trigeminal sensory fiber stimulation induces morphologic changes reflecting secretion in rat dura mast cells. Neuroscience. 44:1991;97-112.
56. Dimitriadou V., Buzzi M.G., Theoharides T.C., Moskowitz M.A. Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience. 48:1992;187-203.
57. Dimitriadou V., Pang X., Theoharides T.C. Hydroxyzine inhibits experimental allergic encephalomyelitis (EAE) and associated brain mast cell activation. Int. J. Immunopharmacol. 22:2000;673-684.
58. Dines K.C., Powell H.C. Mast cell interactions with the nervous system: relationship to mechanisms of disease. J. Neuropathol. Exp. Neurol. 56:1997;627-640.
59. Dvorak A.M., McLeod R.S., Onderdonk A., Monahan-Earley R.A., Cullen J.B., Antonioli D.A., Morgan E., Blair J.E., Estrella P., Cisneros R.L., Silen W., Cohen Z. Ultrastructural evidence for piecemeal and anaphylactic degranulation of human gut mucosal mast cells in vivo. Int. Arch. Allergy Immunol. 99:1992;74-83.
60. Dvorak A.M., McLeod R.S., Onderdonk A.B., Monahan-Earley R.A., Cullen J.B., Antonioli D.A., Morgan E., Blair J.E., Estrella P., Cisneros R.L. Human gut mucosal mast cells: ultrastructural observations and anatomic variation in mast cell-nerve associations in vivo. Int. Arch. Allergy Immunol. 98:1992;158-168.
61. Erickson D.R., Belchis D.A., Dabbs D.J. Inflammatory cell types and clinical features of interstitial cystitis. J. Urol. 158:1997;790-793.
62. Esposito P., Gheorghe D., Kandere K., Pang X., Conally R., Jacobson S., Theoharides T.C. Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res. 888:2001;117-127.
63. Esposito P., Chandler N., Kandere-Grzybowska K., Basu S., Jacobson S., Connolly R., Tutor D., Theoharides T.C. Corticotropin-releasing hormone (CRH) and brain mast cells regulate blood-brain-barrier permeability induced by acute stress. J. Pharmacol. Exp. Ther. 303:2002;1061-1066.
64. Esposito P., Basu S., Letourneau R., Jacobson S., Theoharides T.C. Corticotropin-releasing factor (CRF) can directly affect brain microvessel endothelial cells. Brain Res. 968:2003;192-198.
65. Farthing M.J.G. Irritable bowel, irritable body, or irritable brain? Br. Med. J. 310:1995;171-175.
66. Fewtrell C.M.S., Foreman J.C., Jordan C.C., Oehme P., Renner H., Stewart M. The effects of substance P on histamine and 5-hydroxytryptamine release in the rat. J. Physiol. 330:1982;393-411.
67. Fleisher D.R. The cyclic vomiting syndrome described. J. Pediatr. Gastroenterol. Nutr. 21(Suppl. 1):1995;S1-S5.
68. Fleisher D.R. Cyclic vomiting syndrome: a paroxysmal disorder of brain-gut interaction. J. Pediatr. Gastroenterol. Nutr. 25:1997;S13-S15.
69. Foreman J.C. Neuropeptides and the pathogenesis of allergy. Allergy. 42:1987;1-11.
70. Forman M.B., Oates J.A., Robertson D., Robertson R.M., Roberts L.J. II, Virmani R. Increased adventitial mast cells in a patient with coronary spasm. N. Engl. J. Med. 313:1985;1138-1141.
71. Freeman L.J., Nixon P.G.F., Sallabank P., Reaveley D. Psychological stress and silent myocardial ischemia. Am. Heart J. 114:1987;477-482.
72. Frieling T., Cooke H.J., Wood J.D. Neuroimmune communication in the submucous plexus of guinea pig colon after sensitization to milk antigen. Am. J. Physiol.: Gasterointest. Liver Physiol. 267:1994;1087-1093.
73. Gadek-Michalska A., Chlap Z., Turon M., Bugajski J., Fogel W.A. The intracerebroventicularly administered mast cells degranulator compound 48/80 increases the pituitary-adrenocortical activity in rats. Agents Actions. 32:1991;203-208.
74. Gagari E., Tsai M., Lantz C.S., Fox L.G., Galli S.J. Differential release of mast cell interleukin-6 via c-kit. Blood. 89:1997;2654-2663.
75. Galli S.J. New concepts about the mast cell. N. Engl. J. Med. 328:1993;257-265.
76. Galli S.J., Wedemeyer J., Tsai M. Analyzing the roles of mast cells and basophils in host defense and other biological responses. Int. J. Hematol. 75:2002;363-369.
77. Genovese A., Spadaro G. Highlights in cardiovascular effects of histamine and H1-receptor antagonists. Allergy. 52(Suppl. 34):1997;67-78.
78. Goetzl E.J., Chernov T., Renold F., Payan D.G. Neuropeptide regulation of the expression of immediate hypersensitivity. J. Immunol. 135:1985;802s-805s.
79. Goetzl E.J., Cheng P.P.J., Hassner A., Adelman D.C., Frick O.L., Speedharan S.P. Neuropeptides, mast cells and allergy: novel mechanisms and therapeutic possibilities. Clin. Exp. Allergy. 20:1990;3-7.
80. Goodin D.S., Ebers G.C., Johnson K.P., Rodriguez M., Sibley W.A., Wolinsky J.S. The relationship of MS to physical trauma and psychological stress. Neurology. 52:1999;1737-1745.
81. Gotis-Graham I., Smith M.D., Parker A., McNeil H.P. Synovial mast cell responses during clinical improvement in early rheumatoid arthritis. Ann. Rheum. Dis. 57:1998;664-671.
82. Graham D.T., Wolf S. The relation of eczema to attitude and to vascular reactions of the human skin. J. Lab. Clin. Med. 42:1953;238-254.
83. Gristwood R.W., Lincoln J.C., Owen D.A., Smith I.R. Histamine release from human right atrium. Br. J. Pharmacol. 74:1981;7-9.
84. Gurish M.F., Austen K.F. The diverse roles of mast cells. J. Exp. Med. 194:2001;1-6.
85. Habib K.E., Gold P.W., Chrousos G.P. Neuroendocrinology of stress. Endocrinol. Metab. Clin. N. Am. 30:2001;695-728.
86. Herrmann M., Scholmerich J., Straub R.H. Stress and rheumatic diseases. Rheum. Dis. Clin. North Am. 26:2000;737-763.
87. Hojo H., Sun R., Ono Y., Shishido T., Obara E., Yamazoe Y., Hashimoto Y. Differential production of interleukin-6 and its close relation to liver metastasis in clones from murine P815 mastocytoma. Cancer Lett. 108:1996;55-59.
88. Huang M., Berry J., Kandere K., Lytinas M., Karalis K., Theoharides T.C. Mast cell deficient W/W(v) mice lack stress-induced increase in serum IL-6 levels, as well as in peripheral CRH and vascular permeability, a model of rheumatoid arthritis. Int. J. Immunopathol. Pharmacol. 15:2002;249-254.
89. Huang M., Pang X., Letourneau L., Boucher W., Theoharides T.C. Acute stress induces cardiac mast cell activation and histamine release, effects that are increased in apolipoprotein E knockout mice. Cardiovasc. Res. 55:2002;150-160.
90. Huang M., Pang X., Karalis K., Theoharides T.C. Stress-induced interleukin-6 release in mice is mast cell-dependent and more pronounced in apolipoprotein E knockout mice. Cardiovasc. Res. 59:2003;241-249.
91. Ibrahim M.Z.M., Reder A.T., Lawand R., Takash W., Sallouh-Khatib S. The mast cells of the multiple sclerosis brain. J. Neuroimmunol. 70:1996;131-138.
92. Jarvikallio A., Harvima I.T., Naukkarinen A. Mast cells, nerves and neuropeptides in atopic dermatitis and nummular eczema. Arch. Dermatol. Res. 295:2003;2-7.
93. Jenne D.E., Tschopp J. Angiotensin II-forming heart chymase is a mast-cell-specific enzyme. Biochem. J. 276:1991;567.
94. Joachim R.A., Quarcoo D., Arck P.C., Herz U., Renz H., Klapp B.F. Stress enhances airway reactivity and airway inflammation in an animal model of allergic bronchial asthma. Psychosom. Med. 65:2003;811-815.
95. Johansson S., Fall M. Clinical features and spectrum of light microscopic changes in interstitial cystitis. J. Urol. 143:1990;1118-1124.
96. 2 can stimulate mast cell degranulation. Brain Res. 444:1988;195-198.
97. Kaartinen M., Penttilä A., Kovanen P.T. Accumulation of activated mast cells in the shoulder region of human coronary atheroma, the predilection site of atheromatous rupture. Circulation. 90:1994;1669-1678.
98. Kandere-Grzybowska K., Georghe D., Esposito P., Huang M., Gerard N.P., Theoharides T.C. Stress-induced dura vascular permeability does not develop in mast cell deficient and neurokinin-1 receptor knockout mice. Brain Res. 980:2003;213-220.
99. Kandere-Grzybowska K., Letourneau R., Donelan J., Kempuraj D., Theoharides T.C. Interleukin-1-induced vesicular secretion of interleukin-6 without degranulation from human mast cells. J. Immunol. 171:2003;4830-4836.
100. Kaneko K., Kawana K.K., Arai K., Shibasaki T. Corticotropin-releasing factor receptor type 1 is involved in the stress-induced exacerbation of chronic contact dermatitis in rats. Exp. Dermatol. 12:2003;47-52.
101. Karalis K., Sano H., Redwine J., Listwak S., Wilder R.L., Chrousos G.P. Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science. 254:1991;421-423.
102. Katsarou-Katsari A., Filippou A., Theoharides T.C. Effect of stress and other psychological factors on the pathophysiology and treatment of dermatoses. Int. J. Immunopathol. Pharmacol. 12:1999;7-11.
103. Katsarou-Katsari A., Singh L.K., Theoharides T.C. Alopecia areata and affected skin CRH receptor upregulation induced by acute emotional stress. Dermatology. 203:2001;157-161.
104. Kempuraj D., Papdopoulou N., Lytinas M., Kandere-Grzybowska K., Huang M., Madhappan B., Christodoulou S., Athanassiou A., Theoharides T.C. Human mast cells synthesize and secrete corticotropin-releasing hormone (CRH) which triggers them to secrete IL-6. Endocrinology. 2003;. (in press).
105. Kilpelainen M., Koskenvuo M., Helenius H., Terho E.O. Stressful life events promote the manifestation of asthma and atopic diseases. Clin. Exp. Allergy. 32:2002;256-263.
106. 2 receptors. Eur. J. Endocrinol. 139:1998;238-243.
107. Kobayashi H., Ishizuka T., Okayana Y. Human mast cells amd basophils as sources of cytokines. Clin. Exp. Allergy. 30(9):2000;1205-1212.
108. Kohno M., Kawahito Y., Tsubouchi Y., Hashiramoto A., Yamada R., Inoue K.I., Kusaka Y., Kubo T., Elenkov I.J., Chrousos G.P., Kondo M., Sano H. Urocortin expression in synovium of patients with rheumatoid arthritis and osteoarthritis: relation to inflammatory activity. J. Clin. Endocrinol. Metab. 86:2001;4344-4352.
109. Koldewijn E.L., Hommes O.R., Lemmens W.A.J.G., Debruyne F.M.J., Van Kerrebroeck P.E.V. Relationship between lower urinary tract abnormalities and disease-related parameters in multiple sclerosis. J. Urol. 154:1995;169-173.
110. Kops S.K., Van Loveren H., Rosenstein R.W., Ptak W., Askenase P.W. Mast cell activation and vascular alterations in immediate hypersensitivity-like reactions induced by a T cell derived antigen-binding factor. Lab. Invest. 50:1984;421-434.
111. Kops S.K., Theoharides T.C., Cronin C.T., Kashgarian M.G., Askenase P.W. Ultrastructural characteristics of rat peritoneal mast cells undergoing differential release of serotonin without histamine and without degranulation. Cell Tissue Res. 262:1990;415-424.
112. Koziol J.A., Clark D.C., Gittes R.F., Tan E.M. The natural history of interstitial cystitis: a survey of 374 patients. J. Urol. 149:1993;465-469.
113. Krüger P.G., Bo L., Myhr K.M., Karlsen A.E., Taule A., Nyland H.I., Mork S. Mast cells and multiple sclerosis: a light and electron microscopic study of mast cells in multiple sclerosis emphasizing staining procedures. Acta Neurol. Scand. 81:1990;31-36.
114. Kwon E.E., Prineas J.W. Blood-brain barrier abnormalities in longstanding multiple sclerosis lesions. An immunohistochemical study. J. Neuropathol. Exp. Neurol. 53:1994;625-636.
115. Laine P., Kaartinen M., Penttilä A., Panula P., Paavonen T., Kovanen P.T. Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery. Circulation. 99:1999;361-369.
116. Laine P., Naukkarinen A., Heikkila L., Penttilä A., Kovanen P.T. Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries. Circulation. 101:2000;1665-1669.
117. Laube B.L., Curbow B.A., Costello R.W., Fitzgerald S.T. A pilot study examining the relationship between stress and serum cortisol concentrations in women with asthma. Respir. Med. 96:2002;823-828.
118. Lawrence D.A. Psychologic stress and asthma: neuropeptide involvement. Environ. Health Perspect. 110:2002;A230-A231.
119. Leal-Berumen I., Conlon P., Marshall J.S. IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J. Immunol. 152:1994;5468-5476.
120. Lee D.M., Friend D.S., Gurish M.F., Benoist C., Mathis D., Brenner M.B. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science. 297:2002;1689-1692.
121. Letourneau R., Pang X., Sant G.R., Theoharides T.C. Intragranular activation of bladder mast cells and their association with nerve processes in interstitial cystitis. Br. J. Urol. 77:1996;41-54.
122. Letourneau R., Rozniecki J.J., Dimitriadou V., Theoharides T.C. Ultrastructural evidence of brain mast cell activation without degranulation in monkey EAE. J. Neuroimmunol. 2003;. (in press).
123. Leung D.Y., Diaz L.A., DeLeo V., Soter N.A. Allergic and immunologic skin disorders. JAMA. 278:1997;1914-1923.
124. 2 in rat peritoneal mast cells activated with peptides. Int. Arch. Allergy Appl. Immunol. 90:1989;352-357.
125. Liu L.Y., Coe C.L., Swenson C.A., Kelly E.A., Kita H., Busse W.W. School examinations enhance airway inflammation to antigen challenge. Am. J. Respir. Crit. Care Med. 15(165):2002;1062-1067.
126. Lock C., Hermans G., Pedotti R., Brendolan A., Schadt E., Garren H., Langer-Gould A., Strober S., Cannella B., Allard J., Klonowski P., Austin A., Lad N., Kaminski N., Galli S.J., Oksenberg J.R., Raine C.S., Heller R., Steinman L. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Nat. Med. 8:2002;500-508.
127. Lowry P.J., Woods R.J., Baigent S. Corticotropin releasing factor and its binding protein. Pharmacol. Biochem. Behav. 54:1996;305-308.
128. Lundeberg T., Liedberg H., Nordling L., Theodorsson E., Owzarski A., Ekman P. Interstitial cystitis: correlation with nerve fibres, mast cells and histamine. Br. J. Urol. 71:1993;427-429.
129. Lytinas M., Kempuraj D., Huang M., Boucher W., Esposito P., Theoharides T.C. Acute stress results in skin corticotropin-releasing hormone secretion, mast cell activation and vascular permeability, an effect mimicked by intradermal corticotropin-releasing hormone and inhibited by histamine-1 receptor antagonists. Int. Arch. Allergy Immunol. 130:2003;224-231.
130. Malaviya R., Abraham S.N. Mast cell modulation of immune responses to bacteria. Immunol. Rev. 179:2001;16-24.
131. Marchand J.E., Sant G.R., Kream R.M. Increased expression of substance P receptor-encoding mRNA in bladder biopsies from patients with interstitial cystitis. Br. J. Urol. 81:1998;224-228.
132. Marone G., Galli S.J., Kitamura Y. Probing the roles of mast cells and basophils in natural and acquired immunity. Trends Immunol. 23:2002;425-427.
133. Marquardt D.L., Alongi J.L., Walker L.L. The phosphatidylinositol 3-kinase inhibitor wortmannin blocks mast cell exocytosis but not IL-6 production. J. Immunol. 156:1996;1942-1945.
134. Marshall J.S., Bienenstock J. The role of mast cells in inflammatory reactions of the airways, skin and intestine. Curr. Opin. Immunol. 6:1994;853-859.
135. Marshall J.S., Waserman S. Mast cells and the nerves - potential interactions in the context of chronic disease. Clin. Exp. Allergy. 25:1995;102-110.
136. Matsumoto I., Inoue Y., Shimada T., Aikawa T. Brain mast cells act as an immune gate to the hypothalamic-pituitary-adrenal axis in dogs. J. Exp. Med. 194:2001;71-78.
137. Mattheos S., Christodoulou S., Kempuraj D., Kempuraj B., Karalis K., Theoharides T.C. Mast cells and corticotropin-releasing hormone (CRH) are required for experimental inflammatory arthritis. FASEB J. 17:2003;C44.
138. McEvoy A.N., Bresnihan B., FitzGerald O., Murphy E.P. Corticotropin-releasing hormone signaling in synovial tissue from patients with early inflammatory arthritis is mediated by the type 1α corticotropin-releasing hormone receptor. Arthritis Rheum. 44:2001;1761-1767.
139. Mei-Tal V., Meyerowitz S., Engel G.L. The role of psychological process in a somatic disorder: multiple sclerosis: 1. The emotional setting of illness onset and exacerbation. Psychosom. Med. 32:1970;67-86.
140. Messing E.M., Stamey T.A. Interstitial cystitis: early diagnosis, pathology and treatment. Urology. 12:1978;381-392.
141. Middleton E. Jr., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol. Res. 52:2000;673-751.
142. Mohr D.C., Goodkin D.E., Bacchetti P., Boudewyn A.C., Huang L., Marrietta P., Cheuk W., Dee B. Psychological stress and the subsequent appearance of new brain MRI lesions in MS. Neurology. 55:2000;55-61.
143. Mori N., Suzuki R., Furuno T., McKay D.M., Wada M., Teshima R., Bienenstock J., Nakanishi M. Nerve-mast cell (RBL) interaction: RBL membrane ruffling occurs at the contact site with an activated neurite. Am. J. Physiol., Cell Physiol. 283:2002;C1738-C1744.
144. Newson B., Dahlström A., Enerbäck L., Ahlman H. Suggestive evidence for a direct innervation of mucosal mast cells. Neuroscience. 10:1983;565-570.
145. Noli C., Miolo A. The mast cell in wound healing. Vet. Dermatol. 12:2001;303-313.
146. Odum L., Petersen L.J., Skov P.S., Ebskov L.B. Pituitary adenylate cyclase activating polypeptide (PACAP) is localized in human dermal neurons and causes histamine release from skin mast cells. Inflamm. Res. 47:1998;488-492.
147. Okayama Y., Benyon R.C., Rees P.H., Lowman M.A., Hillier K., Church M.K. Inhibition profiles of sodium cromoglycate and nedocromil sodium on mediator release from mast cells of human skin, lung, tonsil, adenoid and intestine. Clin. Exp. Allergy. 22:1992;401-409.
148. Olness K., Hall H., Rozniecki J.J., Schmidt W., Theoharides T.C. Mast cell activation in child migraine patients before and after training in self-regulation. Headache. 39:1999;101-107.
149. Olsson Y. Mast cells in plaques of multiple sclerosis. Acta Neurol. Scand. 50:1974;611-618.
150. O'Sullivan M., Clayton N., Breslin N.P., Harman I., Bountra C., McLaren A., O'Morain C.A. Increased mast cells in the irritable bowel syndrome. Neurogastroenterol. Motil. 12:2000;449-457.
151. Pang X., Cotreau-Bibbo M.M., Sant G.R., Theoharides T.C. Bladder mast cell expression of high affinity oestrogen receptors in patients with interstitial cystitis. Br. J. Urol. 75:1995;154-161.
152. Pang X., Marchand J., Sant G.R., Kream R.M., Theoharides T.C. Increased number of substance P positive nerve fibers in interstitial cystitis. Br. J. Urol. 75:1995;744-750.
153. Pang X., Letourneau R., Rozniecki J.J., Wang L., Theoharides T.C. Definitive characterization of rat hypothalamic mast cells. Neuroscience. 73:1996;889-902.
154. Pang X., Boucher W., Triadafilopoulos G., Sant G.R., Theoharides T.C. Mast cell and substance P-positive nerve involvement in a patient with both irritable bowel syndrome and interstitial cystitis. Urology. 47:1996;436-438.
155. Pang X., Alexacos N., Letourneau R., Seretakis D., Gao W., Cochrane D.E., Theoharides T.C. A neurotensin receptor antagonist inhibits acute immobilization stress-induced cardiac mast cell degranulation, a corticotropin-releasing hormone-dependent process. J. Pharmacol. Exp. Ther. 287:1998;307-314.
156. Pang X., Sant G.R., Theoharides T.C. Altered expression of bladder mast cell growth factor receptor (c-kit) expression in interstitial cystitis. Urology. 51:1998;939-944.
157. Panula P., Yang H.Y., Costa E. Histamine-containing neurons in the rat hypothalamus. Proc. Natl. Acad. Sci. U. S. A. 81:1984;2572-2576.
158. Park C.H., Joo Y.E., Choi S.K., Rew J.S., Kim S.J., Lee M.C. Activated mast cells infiltrate in close proximity to enteric nerves in diarrhea-predominant irritable bowel syndrome. J. Korean Med. Sci. 18:2003;204-210.
159. Parsons C.L., Lilly J.D., Stein P. Epithelial dysfunction in nonbacterial cystitis (interstitial cystitis). J. Urol. 145:1991;732-735.
160. Patella V., de Crescenzo G., Ciccarelli A., Marino I., Adt M., Marone G. Human heart mast cells: a definitive case of mast cell heterogeneity. Int. Arch. Allergy Immunol. 106:1995;386-393.
161. Pedotti R., DeVoss J.J., Steinman L., Galli S.J. Involvement of both "allergic" and "autoimmune" mechanisms in EAE, MS and other autoimmune diseases. Trends Immunol. 24:2003;479-484.
162. Peeker R., Enerback L., Fall M., Aldenborg F. Recruitment, distribution and phenotypes of mast cells in interstitial cystitis. J. Urol. 163:2000;1009-1015.
163. Pollard H., Bischoff S., Llorens-Cortes C., Schwartz J.C. Histidine decarboxylase and histamine in discrete nuclei of rat hypothalamus and the evidence for mast-cells in the median eminence. Brain Res. 24(118):1976;509-513.
164. Pontari M.A., Hanno P.M. Interstitial cystitis. Walsh P.C., Retik A.B., Stamey T.A., Vaughan E.D. Jr., Wein A.J. Campbell's Urology. 1995;1-19 W.B. Saunders, New York.
165. Pothoulakis C., Castagliulo I., LaMont J.T. Nerves and intestinal mast cells modulate responses to enterotoxins. News Physiol. Sci. 13:1998;58-63.
166. Reuter U., Bolay H., Jansen-Olesen I., Chiarugi A., Sanchez del Rio M., Letourneau R., Theoharides T.C., Waeber C., Moskowitz M.A. Delayed inflammation in rat meninges: implications for migraine pathophysiology. Brain. 124:2001;2490-2502.
167. Rivest S., Laflamme N., Nappi R.E. Immune challenge and immobilization stress induce transcription of the gene encoding the CRF receptor in selective nuclei of the rat hypothalamus. J. Neurosc. 15:1995;2680-2695.
168. Robbie-Ryan M., Tanzola M.B., Secor V.H., Brown M.A. Cutting edge: both activating and inhibitory Fc receptors expressed on mast cells regulate experimental allergic encephalomyelitis disease severity. J. Immunol. 170:2003;1630-1634.
169. Roberts F., Calcutt C.R. Histamine and the hypothalamus. Neuroscience. 9:1983;721-739.
170. Rodewald H.-R., Dessing M., Dvorak A.M., Galli S.J. Identification of a committed precursor for the mast cell lineage. Science. 271:1996;818-822.
171. Rothrock N.E., Lutgendorf S.K., Kreder K.J., Ratliff T., Zimmerman B. Stress and symptoms in patients with interstitial cystitis: a life stress model. Urology. 57:2001;422-427.
172. Rouleau A., Dimitriadou V., Trung Tuong M.D., Newlands G.F., Miller H.R., Schwartz J.C., Garbarg M. Mast cell specific proteases in rat brain: changes in rats with experimental allergic encephalomyelitis. J. Neural Transm. 104:1997;399-417.
173. Rowe W.B., Nicot A., Sharma S., Gully D., Walker C.D., Rostene W.H., Meaney M.J., Quirion R. Central administration of the neurotensin receptor antagonist, SR48692, modulates diurnal and stress-related hypothalamic- pituitary-adrenal activity. Neuroendocrinology. 66:1997;75-85.
174. Rozanski A., Bairey C.N., Krantz D.S., Friedman J., Resser K.J., Morell M., Hilton-Chalfen S., Hestrin L., Bietendorf J., Berman D.S. Mental stress and the induction of silent myocardial ischemia in patients with coronary artery disease. N. Engl. J. Med. 318:1988;1005-1012.
175. Rozniecki J.J., Hauser S.L., Stein M., Lincoln R., Theoharides T.C. Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann. Neurol. 37:1995;63-66.
176. Rozniecki J.J., Dimitriadou V., Lambracht-Hall M., Pang X., Theoharides T.C. Morphological and functional demonstration of rat dura mast cell-neuron interactions in vitro and in vivo. Brain Res. 849:1999;1-15.
177. Saban R., Gerard N.P., Saban M.R., Nguyen N.B., DeBoer D.J., Wershil B.K. Mast cells mediate substance P-induced bladder inflammation through an NK(1) receptor-independent mechanism. Am. J. Physiol., Renal. Physiol. 283:2002;F616-F629.
178. Sant G.R. Interstitial cystitis. Monogr. Urol. 12:1991;37-63.
179. Secor V.H., Secor W.E., Gutekunst C.-A., Brown M.A. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J. Exp. Med. 191:2000;813-821.
180. Seebeck J., Kruse M.L., Schmidt-Choudhury A., Schmidtmayer J., Schmidt W.E. Pituitary adenylate cyclase activating polypeptide induces multiple signaling pathways in rat peritoneal mast cells. Eur. J. Pharmacol. 352:1998;343-350.
181. Schmaling K.B., McKnight P.E., Afari N. A prospective study of the relationship of mood and stress to pulmonary function among patients with asthma. J. Asthma. 39:2002;501-510.
182. Sharma H.S., Cervos-Navarro J., Dey P.K. Increased blood-brain barrier permeability following acute short-term swimming exercise in conscious normotensive young rats. Neurosci. Res. 10:1991;211-221.
183. Sharma H.S., Westman J., Navarro J.C., Dey P.K., Nyberg F. Probable involvement of serotonin in the increased permeability of the blood-brain barrier by forced swimming. An experimental study using Evans blue and 131I-sodium tracers in the rat. Behav. Brain Res. 72:1995;189-196.
184. Sieghart W., Theoharides T.C., Alper S.L., Douglas W.W., Greengard P. Calcium-dependent protein phosphorylation during secretion by exocytosis in the mast cell. Nature. 275:1978;329-331.
185. Singh L.K., Boucher W., Pang X., Letourneau R., Seretakis D., Green M., Theoharides T.C. Potent mast cell degranulation and vascular permeability triggered by urocortin through activation of CRH receptors. J. Pharmacol. Exp. Ther. 288:1999;1349-1356.
186. Singh L.K., Pang X., Alexacos N., Letourneau R., Theoharides T.C. Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin and substance P: a link to neurogenic skin disorders. Brain Behav. Immun. 13:1999;225-239.
187. Skofitsch G., Savitt J.M., Jacobowitz D.M. Suggestive evidence for a functional unit between mast cells and substance P fibers in the rat diaphragm and mesentery. Histochemistry. 82:1985;5-8.
188. Skultetyova I., Tokarev D., Jezova D. Stress-induced increase in blood-brain barrier permeability in control and monosodium glutamate-treated rats. Brain Res. Bull. 45:1998;175-178.
189. Slominski A., Wortsman J. Neuroendocrinology of the skin. Endocr. Rev. 21:2000;457-487.
190. Slominski A., Wortsman J., Luger T., Paus R., Solomon S. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol. Rev. 80:2000;979-1020.
191. Slominski A., Wortsman J., Pisarchik A., Zbytek B., Linton E.A., Mazurkiewicz J.E., Wei E.T. Cutaneous expression of corticotropin-releasing hormone (CRH), urocortin, and CRH receptors. FASEB J. 15:2001;1678-1693.
192. Spanos C.P., Pang X., Ligris K., Letourneau R., Alferes L., Alexacos N., Sant G.R., Theoharides T.C. Stress-induced bladder mast cell activation: implications for interstitial cystitis. J. Urol. 157:1977;669-672.
193. Spanos C., el-Mansoury M., Letourneau R., Minogiannis P., Greenwood J., Siri P., Sant G.R., Theoharides T.C. Carbachol-induced bladder mast cell activation: augmentation by estradiol and implications for interstitial cystitis. Urology. 48:1996;809-816.
194. Spierings E.L. Pathogenesis of the migraine attack. Clin. J. Pain. 19:2003;255-262.
195. Sundaram K., Didolkar A., Thau R., Chaudhuri M., Schmidt F. Antagonists of luteinizing hormone releasing hormone bind to rat mast cells and induce histamine release. Agents Actions. 25:1988;307-313.
196. Suzuki R., Furuno T., McKay D.M., Wolvers D., Teshima R., Nakanishi M., Bienenstock J. Direct neurite-mast cell communication in vitro occurs via the neuropeptide substance P. J. Immunol. 163:1999;2410-2415.
197. Suzuki M., Inaba S., Nagai T., Tatsuno H., Kazatani Y. Relation of C-reactive protein and interleukin-6 to culprit coronary artery plaque size in patients with acute myocardial infarction. Am. J. Cardiol. 91:2003;331-333.
198. Tetlow L.C., Woolley D.E. Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion. Ann. Rheum. Dis. 54:1995;549-555.
199. Theoharides T.C. Mast cells and migraines. Perspect. Biol. Med. 26:1983;672-675.
200. Theoharides T.C. Mast cells: the immune gate to the brain. Life Sci. 46:1990;607-617.
201. Theoharides T.C. The mast cell: a neuroimmunoendocrine master player. Int. J. Tissue React. 18:1996;1-21.
202. Theoharides T.C. Mast cells and stress - a psychoneuroimmunological perspective. J. Clin. Psychopharmacol. 22:2002;103-108.
203. Theoharides T.C. Dietary supplements for arthritis and other inflammatory conditions: key role of mast cells and benefit of combining anti-inflammatory and proteoglycan products. Eur. J. Inflamm. 1:2003;1-8.
204. Theoharides T.C., Douglas W.W. Secretion in mast cells induced by calcium entrapped within phospholipid vesicles. Science. 201:1978;1143-1145.
205. Theoharides T.C., Sant G.R. The role of the mast cell in interstitial cystitis. Urol. Clin. North Am. 21:1994;41-53.
206. Theoharides T.C., Sieghart W., Greengard P., Douglas W.W. Antiallergic drug cromolyn may inhibit histamine secretion by regulating phosphorylation of a mast cell protein. Science. 207:1980;80-82.
207. Theoharides T.C., Bondy P.K., Tsakalos N.D., Askenase P.W. Differential release of serotonin and histamine from mast cells. Nature. 297:1982;229-231.
208. Theoharides T.C., Dimitriadou V., Letourneau R.J., Rozniecki J.J., Vliagoftis H., Boucher W.S. Synergistic action of estradiol and myelin basic protein on mast cell secretion and brain demyelination: changes resembling early stages of demyelination. Neuroscience. 57:1993;861-871.
209. Theoharides T.C., Sant G.R., El-Mansoury M., Letourneau R.J., Ucci A.A. Jr., Meares E.M. Jr. Activation of bladder mast cells in interstitial cystitis: a light and electron microscopic study. J. Urol. 153:1995;629-636.
210. Theoharides T.C., Spanos C.P., Pang X., Alferes L., Ligris K., Letourneau R., Rozniecki J.J., Webster E., Chrousos G. Stress-induced intracranial mast cell degranulation. A corticotropin releasing hormone-mediated effect. Endocrinology. 136:1995;5745-5750.
211. Theoharides T.C., Pang X., Letourneau R., Sant G.R. Interstitial cystitis: a neuroimmunoendocrine disorder. Ann. N.Y. Acad. Sci. 840:1998;619-634.
212. Theoharides T.C., Singh L.K., Boucher W., Pang X., Letourneau R., Webster E., Chrousos G. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its pro-inflammatory effects. Endocrinology. 139:1998;403-413.
213. Theoharides T.C., Letourneau R., Patra P., Hesse L., Pang X., Boucher W., Mompoint C., Harrington B. Stress-induced rat intestinal mast cell intragranular activation and inhibitory effect of sulfated proteoglycans. Dig. Dis. Sci. 144(Suppl. 8):1999;87S-93S.
214. Theoharides T.C., Patra P., Boucher W., Letourneau R., Kempuraj D., Chiang G., Jeudy S., Hesse L., Athanasiou A. Chondroitin sulfate inhibits connective tissue mast cells. Br. J. Pharmacol. 131:2000;10139-10149.
215. Theoharides T.C., Kempuraj D., Sant G.R. Mast cell involvement in interstitial cystitis: a review of human and experimental evidence. Urology. 57(6 Suppl. 1):2001;47-55.
216. Theoharides T.C., Alexandrakis M., Kempuraj D., Zytinas M. Anti-inflammatory actions of flavonoides and structural requirements for new design. Int. J. Immunopathol. Pharmacol. 14(3):2001;119-127.
217. Theoharides T.C., Stein M., Spear K., Hauser S. A pilot, double-blind, placebo-controlled clinical trial using hydroxyzine in remitting-relapsing multiple sclerosis (RR-MS). Pharmacologist. 44:2002;A165.
218. Theoharides T.C., Donelan J., Kandere-Grzybowska K. Stress, corticotropin-releasing hormone and brain mast cells: a new model for the pathogenesis of migraines. Brain Res. 2004;. (In press).
219. Thomason B.T., Brantley P.J., Jones G.N., Dyer H.R., Morris J.L. The relation between stress and disease activity in rheumatoid arthritis. J. Behav. Med. 15:1992;215-220.
220. Tompkins S.M., Miller S.D. An array of possibilities for multiple sclerosis. Nat. Med. 8:2002;451-453.
221. Toms R., Weiner H.L., Johnson D. Identification of IgE-positive cells and mast cells in frozen sections of multiple sclerosis brains. J. Neuroimmunol. 30:1990;169-177.
222. Toyoda M., Makino T., Kagoura M., Morohashi M. Immunolocalization of substance P in human skin mast cells. Arch. Dermatol. Res. 292:2000;418-421.
223. Tuomisto L., Kilpeläinen H., Riekkinen P. Histamine and histamine-N-methyltransferase in the CSF of patients with multiple sclerosis. Agents Actions. 13:1983;255-257.
224. Uzuki M., Sasano H., Muramatsu Y., Totsune K., Takahashi K., Oki Y., Iino K., Sawai T. Urocortin in the synovial tissue of patients with rheumatoid arthritis. Clin. Sci. 100:2001;577-589.
225. van der Kleij H.P., Ma D., Redegeld F.A., Kraneveld A.D., Nijkamp F.P., Bienenstock J. Functional expression of neurokinin 1 receptors on mast cells induced by IL-4 and stem cell factor. J. Immunol. 171:2003;2074-2079.
226. van Haaster C.M.C.J., Engels W., Lemmens P.J.M.R., Hornstra G., van der Vusse G.J., Heemskerk J.W.M. Differential release of histamine and prostaglandin D2 in rat peritoneal mast cells; roles of cytosolic calcium and protein tyrosine kinases. Biochim. Biophys. Acta. 1265:1995;79-88.
227. Van Loveren H., Kops S.K., Askenase P.W. Different mechanisms of release of vasoactive amines by mast cells occur in T cell-dependent compared to IgE-dependent cutaneous hypersensitivity responses. Eur. J. Immunol. 14:1984;40-47.
228. Vliagoftis H., Dimitriadou V., Boucher W., Rozniecki J.J., Correia I., Raam S., Theoharides T.C. Estradiol augments while tamoxifen inhibits rat mast cell secretion. Int. Arch. Allergy Immunol. 98:1992;398-409.
229. von Hertzen L.C. Maternal stress and T-cell differentiation of the developing immune system: possible implications for the development of asthma and atopy. J. Allergy Clin. Immunol. 109:2002;923-928.
230. Warren S., Greenhill S., Warren K.G. Emotional stress and the development of multiple sclerosis: case control evidence of a relationship. J. Chronic. Dis. 35:1982;821-831.
231. Webster E.L., Barrientos R.M., Contoreggi C., Isaac M.G., Ligier S., Gabry K.E., Chrousos G.P., McCarthy E.F., Rice K.C., Gold P.W., Sternberg E.M. Corticotropin releasing hormone (CRH) antagonist attenuates adjuvant induced arthritis: role of CRH in peripheral inflammation. J. Rheumatol. 29:2002;1252-1261.
232. Weston A.P., Biddle W.L., Bhatia P.S., Miner P.B. Jr. Terminal ileal mucosal mast cells in irritable bowel syndrome. Dig. Dis. Sci. 38:1993;1590-1595.
233. Wiesner-Menzel L., Schulz B., Vakilzadeh F., Czarnetzki B.M. Electron microscopical evidence for a direct contact between nerve fibers and mast cells. Acta Derm. - Venereol. (Stockh). 61:1981;465-469.
234. Williams C.L., Peterson J.M., Villar R.G., Burks T.F. Corticotropin-releasing factor directly mediates colonic responses to stress. Am. J. Physiol. 253:1987;582-586.
235. Williams R.M., Bienenstock J., Stead R.H. Mast cells: the neuroimmune connection. Chem. Immunol. 61:1995;208-235.
236. Woolley D.E. Mast cells in the rheumatoid lesion - ringleaders or innocent bystanders. Ann. Rheum. Dis. 54:1995;533-534.
237. Xiang Z., Nilsson G. IgE receptor-mediated release of nerve growth factor by mast cells. Clin. Exp. Allergy. 30:2000;1379-1386.
238. Yamatodani A., Maeyama K., Watanabe T., Wada H., Kitamura Y. Tissue distribution of histamine in a mutant mouse deficient in mast cells: clear evidence for the presence of non-mast-cell histamine. Biochem. Pharmacol. 31:1982;305-309.
239. Woolley D.E. The mast cell in inflammatory arthritis. N. Engl. J. Med. 348:2003;1709-1711.
240. Zhao X.J., McKerr G., Dong Z., Higgins C.A., Carson J., Yang Z.Q., Hannigan B.M. Expression of oestrogen and progesterone receptors by mast cells alone, but not lymphocytes, macrophages or other immune cells in human upper airways. Thorax. 56:2001;205-211.
241. Zhuang X., Silverman A.-J., Silver R. Brain mast cell degranulation regulates blood-brain barrier. J. Neurobiol. 31:1996;393-403.